← Leaderboards
Chris A Mink
La Biomed Res Inst/ Harbor Ucla Med Ctr
$238,960
Attributed
$238,960
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$238,960 · 1
By mechanism
M01$238,960 · 1
Top collaborators
No co-investigators on record.
Most similar at La Biomed Res Inst/ Harbor Ucla Med Ctr
Same institution · by research overlap
- John E. Edwards$7,345,861
- Margaret A Keller$2,116,833
- Thomas R Kozel$22,208,837
- Christina C. Wang$7,924,844
- Sharon G Adler$6,091,045
Others in their field
Top investigators on “Active Immunization”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$466,593,725
- Judith S. Currier · University Of California Los Angeles$322,872,111
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$256,197,143
- Daniel R Kuritzkes · Brigham And Women'S Hospital$217,875,923
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
Research focus
Active ImmunizationAdolescence (12-20)Adult Human (21+)Bordetella PertussisClinical ResearchDrug Screening /EvaluationEpidemiologyHuman SubjectPathologic ProcessPertussisPertussis Vaccine
Grant awards (4)
ACELLULAR PERTUSSIS VACCINE EFFICACY IN ADOLESCENTS AND ADULTS$237,978
M01 · FY2001 · RR
ACELLULAR PERTUSSIS VACCINE EFFICACY IN ADOLESCENTS AND ADULTS$982
M01 · FY2000 · RR
ACELLULAR PERTUSSIS VACCINE EFFICACY IN ADOLESCENTS AND ADULTS$0
M01 · FY2000 · RR
ACELLULAR PERTUSSIS VACCINE EFFICACY IN ADOLESCENTS AND ADULTS$0
M01 · FY2000 · RR